July 2015

CYTOO unveils MyoScreenФ™, a new platform for the discovery of drug candidates for muscle disorders
16 July 2015
Grenoble, France, 16th July 2015 - CYTOO, a biotechnology company specialized in the development of physiologically-relevant high content cellular assays, announces today the commercial launch of MyoScreenФ™, a new screening platform for the identification of novel active molecules that can be used to treat musculoskeletal and neuromuscular disorders. CYTOO, the first in the world to model a human muscle in vitro By combining the technology of adhesive micropatterns with muscle cells isolated from human donors, CYTOO has created the first in vitro model of mature human muscle....
Download info read more